You have 9 free searches left this month | to do more

carboplatin

Carboplatin is a drug used to treat Lung Cancer, Ovarian Cancer, Breast Cancer, and other conditions. Carboplatin is being actively studied in 635 studies and prior, has been studied in 821.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Washington University School of MedicineEdward Neuwelt
M.D. Anderson Cancer CenterRoswell Park Cancer InstituteH.W.M. van Laarhoven
Eli Lilly and CompanyUniversity of Oklahoma Health Sciences CenterAjay Gopal
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
  • Non-small Cell Lung Cancer
  • Seoul, Gangnamgu, Korea, Republic of
    Samsung Medical Center
2021-12-27
Dec 27, 2021
S
Terminated
  • Breast Neoplasm
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
2022-03-28
Mar 28, 2022
N
Active, not recruiting
  • Adult Solid Neoplasm
  • Carboplatin
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
2021-12-14
Dec 14, 2021
U
Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Carboplatin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-10
Mar 10, 2022
T
Active, not recruiting
  • Breast Cancer
  • Amsterdam, Netherlands
  • +3 more
2022-03-21
Mar 21, 2022
U
Active, not recruiting
  • Triple Negative Breast Cancer
  • Carboplatin
  • +3 more
  • Chicago, Illinois
    University of Illinois
2022-01-28
Jan 28, 2022
A
Completed
  • Advanced Solid Tumors
  • veliparib (ABT-888)
  • +2 more
  • (no location specified)
2021-07-29
Jul 29, 2021
H
Active, not recruiting
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-12-13
Dec 13, 2021
S
Active, not recruiting
  • Testicular Neoplasms
  • Seminoma
  • Bleomycin Etoposide and Cisplatin
  • Carboplatin
  • Trondheim, Norway
    Institutt for kreftforskning og molekylær medisin, St Olavs Hosp
2021-11-05
Nov 5, 2021
U
Recruiting
  • Non-Small Cell Lung Cancer Metastatic
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
2022-03-01
Mar 1, 2022
L
Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
2021-09-08
Sep 8, 2021
U
Completed
  • Metastatic Medulloblastoma
  • +2 more
  • Carboplatin
  • +2 more
  • Aurora, Colorado
    Children's Hospital Colorado
2021-12-13
Dec 13, 2021
N
Completed
  • Ependymoma
  • Anaplastic Ependymoma
  • Boston, Massachusetts
  • +1 more
2021-11-29
Nov 29, 2021
i
Completed
  • Carcinoma, Non-Small-Cell Lung
  • Freiburg, Baden-Württemberg, Germany
    iOMEDICO
2021-10-05
Oct 5, 2021
A
Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +2 more
2022-03-02
Mar 2, 2022
A
Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-02-05
Feb 5, 2022
G
Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
2021-10-15
Oct 15, 2021
U
Terminated
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Carboplatin
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2021-09-03
Sep 3, 2021
N
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Carboplatin
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
2022-01-25
Jan 25, 2022
U
Completed
  • Castration Levels of Testosterone
  • +5 more
  • Carboplatin
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-01-24
Jan 24, 2022
M
Recruiting
  • Fallopian Tube Cancer
  • +2 more
  • Miami, Florida
    University of Miami
2021-12-24
Dec 24, 2021
A
Completed
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Carboplatin
  • +2 more
  • Bronx, New York
  • +2 more
2021-10-18
Oct 18, 2021
M
Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Carboplatin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-24
Mar 24, 2022
G
Recruiting
  • Solid Tumor, Adult
  • Homologous Recombination Deficiency
  • Washington, District of Columbia
  • +2 more
2021-08-31
Aug 31, 2021